Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App




Handheld Pen Enables Real-Time Tissue Identification during Surgery

By LabMedica International staff writers
Posted on 30 Aug 2023

Thyroid and parathyroid gland surgeries pose significant challenges, even for experienced surgeons. These relatively small neck structures share characteristics like color and texture, complicating visual differentiation. For instance, during thyroid removal procedures, accidental parathyroid removal occurs in about 25% of cases. Similarly, unsuccessful parathyroid removals often result from the inability to locate and resect diseased parathyroid tissue, as thyroid nodules and lymph nodes can be mistaken for parathyroid tissue. There is a critical need for innovative methods to preserve healthy tissue and ensure precise resection.

In a new project, surgeons at Baylor College of Medicine (Houston, TX, USA) extensively tested the MasSpec Pen during thyroid and parathyroid surgeries. In the operating room, the MasSpec Pen helps surgeons identify tissues for resection before actually performing the procedure, ensuring accurate tissue removal without unnecessary damage. Integrating seamlessly into the surgical workflow, the pen can be sterilized like other instruments and simply connected to the mass spectrometer. Its intuitive use holds immense potential for saving time during surgery. The pen primarily detects small molecules like metabolites (cell metabolism byproducts) and lipids created by cells. Each tissue has a unique metabolite and lipid pattern. While many molecules are similar across tissues, their concentrations vary based on tissue type, enabling surgeons to differentiate tissues. The process is simple: the surgeon places the pen gently on the tissue, which deposits a droplet of room-temperature sterile water, extracting small molecules. The droplet is then directed to a real-time mass spectrometer that reveals the tissue's molecular composition, indicating its type. Importantly, this procedure does not harm the analyzed tissues.

In order to assess the precision of this novel technology, the scientists conducted a comparison between the tissue identification outcomes produced by the MasSpec Pen and the well-established method of tissue identification—pathology analysis. Pathologists are experts who specialize in microscopically discerning tissue samples. The MasSpec Pen exhibited exceptional accuracy in distinguishing thyroid, parathyroid, and lymph node tissues during surgeries, achieving accuracy rates exceeding 90%. Results from the MasSpec Pen analysis were available in around 20 seconds, whereas processing samples for pathology analysis (referred to as frozen section) during surgery can extend to an hour, thus saving both procedure time and cost. Typically, prolonged surgeries heighten the risk of complications. The use of the MasSpec Pen offers the benefit of real-time tissue identification during surgical procedures, enhancing patient care.

“The MasSpec Pen could be applied to surgeries of other organs, such as lungs or pancreas,” said co-corresponding author Dr. James Suliburk, associate professor of surgery and member of the Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine. “We think this can really revolutionize how we do surgery.”

Related Links:
Baylor College of Medicine

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.